Personalised management of community-acquired pneumonia and the role of Clinical Decision Support Software
Clinical Snapshot
PICO Framework
| P — Population | Patients with community-acquired pneumonia requiring hospital management |
| I — Intervention | Clinical Decision Support Software (CDSS) for CAP management |
| C — Comparator | Standard care without CDSS or traditional guideline-based management |
| O — Outcomes | Antibiotic prescribing patterns, adherence to guidelines, clinical outcomes, antimicrobial resistance |
Bottom Line
This narrative review examines Clinical Decision Support Software for community-acquired pneumonia management, highlighting potential benefits for antimicrobial stewardship. However, the review lacks systematic methodology, making it unsuitable for evidence-based practice recommendations. While CDSS represents a promising approach to address antibiotic overprescribing and improve guideline adherence in CAP, the current evidence base requires systematic evaluation through properly conducted systematic reviews and meta-analyses. Clinicians should await higher-quality evidence synthesis before implementing CDSS-based changes to CAP management protocols. The topic remains clinically relevant given rising antimicrobial resistance concerns.
Key Findings
Effect Size: Not quantified - narrative synthesis only
Primary Outcome: Evidence review of CDSS effectiveness in CAP management
Nnt Or Sensitivity: Not calculated
Confidence Interval: Not provided
Clinical Application
Implementation dependent on healthcare system digital infrastructure and clinician acceptance Relevant to Australian hospitals with electronic medical records; aligns with National Antimicrobial Resistance Strategy and TGA antimicrobial stewardship initiatives Hospital-based clinicians managing community-acquired pneumonia
Abstract
Community-acquired pneumonia (CAP) is one of the most common causes of hospital admission and is associated with significant morbidity and mortality. National and international guidelines are available to guide the management of CAP, including antibiotic prescribing. However, these guidelines are often not adhered to and there is significant overprescribing of broad-spectrum antibiotics, contributing to the growing pandemic of antimicrobial resistance. Clinical Decision Support Software (CDSS) are electronic tools that use individual patient data to generate patient specific assessments or recommendations, that can then be acted on by the patient or clinical decision maker. This article reviews the evidence surrounding the initial management of CAP in hospital and considers the potential of CDSS to support CAP management.
References
- 1.Hatton, C., Atkin, C., Gallier, S., & Sapey, E. (2026). Personalised management of community-acquired pneumonia and the role of Clinical Decision Support Software. BMJ Open Respiratory Research, 13(1), e003096. https://doi.org/10.1136/bmjresp-2024-003096
Related Research
Sleep medicine
Concordance of wearable device sleep metrics with patient-reported sleep quality: A systematic review
3 Aug 2026
Bioelectrochemistry (Amsterdam, Netherlands)
From data to diagnosis: A comprehensive review of machine learning-driven wearable sensors in healthcare.
2 Aug 2026
JMIR mHealth and uHealth
Wearable Devices for Monitoring and Management of Comorbid Obstructive Sleep Apnea and Hypertension: Scoping Review
1 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service